Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v4-FR
Language English French
Date Updated 2019-08-12 2019-06-28
Drug Identification Number 02230019 02230019
Brand name VIOKACE VIOKACE
Common or Proper name Viokace 10440 Viokace 10440
Company Name NESTLE ENTERPRISES S.A. NESTLE ENTERPRISES S.A.
Ingredients AMYLASE PROTEASE LIPASE AMYLASE PROTEASE LIPASE
Strength(s) 56400UNIT 57100UNIT 10440UNIT 56400UNIT 57100UNIT 10440UNIT
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100's bottle 100's bottle
ATC code A09AA A09AA
ATC description DIGESTIVES, INCL ENZYMES DIGESTIVES, INCL ENZYMES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-07-12 2019-07-05
Actual start date 2019-07-12
Estimated end date 2019-08-16 2019-08-05
Actual end date 2019-08-12
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Viokace 20880 remains in stock and available Viokace 20880 remains in stock and available
Health Canada comments